AJJARAPU SURENDRA K enters ASPIRE BIOPHARMA HOLDINGS, INC. with 4.32M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 8/28/2023ACC: 0001493152-23-030377
DirectorOfficer10% Owner· Chief Executive Officer
Since Aug 2023
4.32M
Baseline shares
0.00
Direct ownership
0 positions
6.83M
Derivative underlying
1 instrument
1
Security positions
4.32M indirect
Non-Derivative Holdings1
Class A Ordinary Shares
IndirectShares owned4.32M
Total
4.32M indirect4.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Ordinary Shares | 4.32M | Indirect |
| Total | 4.32M | 4.32M indirect |
Derivative Holdings1
Warrants
IndirectUnderlying security
Class A Ordinary Shares
Underlying shares
6.83M
Shares owned
N/A
Exercise price
11.50
Expiration
—
Exercise window
—
Total
Underlying
6.83M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants Indirect | Class A Ordinary Shares | 11.50 | — | — | 6.83M | N/A |
| Total | 6.83M | 0.00 | ||||